These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34170637)

  • 1. Animal Models of Multiple Sclerosis.
    Smith P
    Curr Protoc; 2021 Jun; 1(6):e185. PubMed ID: 34170637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment.
    Robinson AP; Harp CT; Noronha A; Miller SD
    Handb Clin Neurol; 2014; 122():173-89. PubMed ID: 24507518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison.
    Dal Canto MC; Melvold RW; Kim BS; Miller SD
    Microsc Res Tech; 1995 Oct; 32(3):215-29. PubMed ID: 8527856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Glycolipid Antibody Examination in Five EAE Models and Theiler's Virus Model of Multiple Sclerosis: Detection of Anti-GM1, GM3, GM4, and Sulfatide Antibodies in Relapsing-Remitting EAE.
    Moriguchi K; Nakamura Y; Park AM; Sato F; Kuwahara M; Khadka S; Omura S; Ahmad I; Kusunoki S; Tsunoda I
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.
    Fuller KG; Olson JK; Howard LM; Croxford JL; Miller SD
    Methods Mol Med; 2004; 102():339-61. PubMed ID: 15286394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.
    McCarthy DP; Richards MH; Miller SD
    Methods Mol Biol; 2012; 900():381-401. PubMed ID: 22933080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curdlan, a Microbial β-Glucan, Has Contrasting Effects on Autoimmune and Viral Models of Multiple Sclerosis.
    Sato F; Nakamura Y; Katsuki A; Khadka S; Ahmad I; Omura S; Martinez NE; Tsunoda I
    Front Cell Infect Microbiol; 2022; 12():805302. PubMed ID: 35198458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: implications for remyelination at lesions sites.
    Mecha M; Feliú A; Carrillo-Salinas FJ; Mestre L; Guaza C
    Exp Neurol; 2013 Dec; 250():348-52. PubMed ID: 24148569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus.
    Tsunoda I; Fujinami RS
    J Neuropathol Exp Neurol; 1996 Jun; 55(6):673-86. PubMed ID: 8642393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relevance of animal models in multiple sclerosis research.
    Denic A; Johnson AJ; Bieber AJ; Warrington AE; Rodriguez M; Pirko I
    Pathophysiology; 2011 Feb; 18(1):21-9. PubMed ID: 20537877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical model of multiple sclerosis: Methods in autoimmune demyelination.
    Nissen JC; Tsirka SE
    Methods Cell Biol; 2022; 168():67-86. PubMed ID: 35366992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential influence of interleukin-12 in the pathogenesis of autoimmune and virus-induced central nervous system demyelination.
    Bright JJ; Rodriguez M; Sriram S
    J Virol; 1999 Feb; 73(2):1637-9. PubMed ID: 9882371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models of Multiple Sclerosis.
    Procaccini C; De Rosa V; Pucino V; Formisano L; Matarese G
    Eur J Pharmacol; 2015 Jul; 759():182-91. PubMed ID: 25823807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct roles for IP-10/CXCL10 in three animal models, Theiler's virus infection, EAE, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10.
    Tsunoda I; Lane TE; Blackett J; Fujinami RS
    Mult Scler; 2004 Feb; 10(1):26-34. PubMed ID: 14760949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo models of multiple sclerosis.
    van der Star BJ; Vogel DY; Kipp M; Puentes F; Baker D; Amor S
    CNS Neurol Disord Drug Targets; 2012 Aug; 11(5):570-88. PubMed ID: 22583443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental strategies to promote central nervous system remyelination in multiple sclerosis: insights gained from the Theiler's virus model system.
    Miller DJ; Asakura K; Rodriguez M
    J Neurosci Res; 1995 Jun; 41(3):291-6. PubMed ID: 7563222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease.
    Ben-Nun A; Mendel I; Bakimer R; Fridkis-Hareli M; Teitelbaum D; Arnon R; Sela M; Kerlero de Rosbo N
    J Neurol; 1996 Apr; 243(4 Suppl 1):S14-22. PubMed ID: 8965116
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Lima C; Maleski ALA; Bernardo JTG; Zelli VC; Komegae EN; Lopes-Ferreira M
    Front Immunol; 2022; 13():857692. PubMed ID: 35401524
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune promotion of central nervous system remyelination.
    Rodriguez M; Miller DJ
    Prog Brain Res; 1994; 103():343-55. PubMed ID: 7886217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.